- Home
- APVO vs TCRT Comparison
APVO vs TCRT Comparison
Compare APVO & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- TCRT
- Stock Information
- Founded
- APVO 2016
- TCRT 1998
- Country
- APVO United States
- TCRT United States
- Employees
- APVO N/A
- TCRT N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- APVO Health Care
- TCRT Health Care
- Exchange
- APVO Nasdaq
- TCRT Nasdaq
- Market Cap
- APVO 3.7M
- TCRT 3.8M
- IPO Year
- APVO N/A
- TCRT N/A
- Fundamental
- Price
- APVO $0.21
- TCRT $2.08
- Analyst Decision
- APVO Strong Buy
- TCRT
- Analyst Count
- APVO 1
- TCRT 0
- Target Price
- APVO $8.00
- TCRT N/A
- AVG Volume (30 Days)
- APVO 17.5M
- TCRT 14.2K
- Earning Date
- APVO 11-07-2024
- TCRT 11-14-2024
- Dividend Yield
- APVO N/A
- TCRT N/A
- EPS Growth
- APVO N/A
- TCRT N/A
- EPS
- APVO N/A
- TCRT N/A
- Revenue
- APVO N/A
- TCRT $7,000.00
- Revenue This Year
- APVO N/A
- TCRT N/A
- Revenue Next Year
- APVO N/A
- TCRT N/A
- P/E Ratio
- APVO N/A
- TCRT N/A
- Revenue Growth
- APVO N/A
- TCRT N/A
- 52 Week Low
- APVO $0.14
- TCRT $1.95
- 52 Week High
- APVO $10.80
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- APVO 43.68
- TCRT 44.32
- Support Level
- APVO $0.24
- TCRT $2.00
- Resistance Level
- APVO $0.33
- TCRT $2.86
- Average True Range (ATR)
- APVO 0.04
- TCRT 0.17
- MACD
- APVO -0.01
- TCRT 0.05
- Stochastic Oscillator
- APVO 0.70
- TCRT 14.29
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.